Fortfahren mit
Größe auswählen
| Ihnen/SKU | Verfügbarkeit | Preis |
|---|---|---|
125 mg | Warenkorb auf Verfügbarkeit prüfen | CHF 3’460.00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
cabergoline
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1
InChI
1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1
InChI key
KORNTPPJEAJQIU-KJXAQDMKSA-N
Gene Information
human ... DRD2(1813)
General description
For further information and support please go to the website of the issuing Pharmacopoeia.
Biochem/physiol Actions
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade - | grade pharmaceutical primary standard |
| manufacturer/tradename USP | manufacturer/tradename EDQM | manufacturer/tradename - | manufacturer/tradename USP |
| format neat | format neat | format - | format neat |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) - | application(s) pharmaceutical (small molecule) |
| Gene Information human ... DRD2(1813) | Gene Information human ... DRD2(1813) | Gene Information human ... DRD2(1813) | Gene Information - |
| API family cabergoline | API family cabergoline | API family - | API family candesartan |
Still not finding the right product?
Explore all of our products under Cabergolin
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Lact.
Lagerklasse
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.


